Source: Molecular neurobiology. Unidade: FM
Subjects: PESQUISA BIOMÉDICA, TÉCNICAS GENÉTICAS, TRAUMATISMOS DA MEDULA ESPINHAL, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASCHON, Vera et al. CRISPR, prime editing, optogenetics, and DREADDs: new therapeutic approaches provided by emerging technologies in the treatment of spinal cord injury. Molecular neurobiology, v. 57, n. 4, p. 2085-2100, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12035-019-01861-w. Acesso em: 19 out. 2024.APA
Paschon, V., Correia, F. F., Morena, B. C., Silva, V. A. da, Santos, G. B. dos, Silva, M. C. C. da, et al. (2020). CRISPR, prime editing, optogenetics, and DREADDs: new therapeutic approaches provided by emerging technologies in the treatment of spinal cord injury. Molecular neurobiology, 57( 4), 2085-2100. doi:10.1007/s12035-019-01861-wNLM
Paschon V, Correia FF, Morena BC, Silva VA da, Santos GB dos, Silva MCC da, Cristante AF, Willerth SM, Perrin FE, Kihara AH. CRISPR, prime editing, optogenetics, and DREADDs: new therapeutic approaches provided by emerging technologies in the treatment of spinal cord injury [Internet]. Molecular neurobiology. 2020 ; 57( 4): 2085-2100.[citado 2024 out. 19 ] Available from: https://doi.org/10.1007/s12035-019-01861-wVancouver
Paschon V, Correia FF, Morena BC, Silva VA da, Santos GB dos, Silva MCC da, Cristante AF, Willerth SM, Perrin FE, Kihara AH. CRISPR, prime editing, optogenetics, and DREADDs: new therapeutic approaches provided by emerging technologies in the treatment of spinal cord injury [Internet]. Molecular neurobiology. 2020 ; 57( 4): 2085-2100.[citado 2024 out. 19 ] Available from: https://doi.org/10.1007/s12035-019-01861-w